We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $446M
1-Year Est. Return 13.33%
This Fund
S&P 500
This Quarter Est. Return
-1.65%
1 Year Est. Return
+13.33%
3 Year Est. Return
+41.32%
5 Year Est. Return
+5.19%
10 Year Est. Return
+180.06%
AUM
$1.51B
AUM Growth
-$59.4M
Cap. Flow
+$92.2M
Cap. Flow %
6.09%
Top 10 Hldgs %
50.09%
Holding
339
New
32
Increased
81
Reduced
57
Closed
39

Sector Composition

Rank Sector Weight
1 Healthcare 42.69%
2 Miscellaneous 29.56%
3 Communication Services 8.19%
4 Financials 5.48%
5 Industrials 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
$145M 9.58%
16,470,258
-1,000
-0% -$8.12K
AMRX icon
2
Amneal Pharmaceuticals
AMRX
$6.07B
$140M 9.25%
19,552,001
SINA
3
DELISTED
Sina Corp
SINA
$84.5M 5.58%
1,960,066
-7,512
-0.4% -$394K
BEST
4
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$38M 2.51%
345,046
+13,345
+4% +$1.38M
DBRG icon
5
DigitalBridge
DBRG
$2.99B
$33.8M 2.23%
1,692,324
-718,137
-30% -$14.9M
GILD icon
6
Gilead Sciences
GILD
$187B
$27.3M 1.8%
404,973
+8,530
+2% +$561K
NATR icon
7
Nature's Sunshine
NATR
$247M
$26.5M 1.75%
2,854,607
ARRY
8
DELISTED
Array Biopharma Inc
ARRY
$23.1M 1.52%
498,733
+114,678
+30% +$3.22M
SOHU
9
Sohu.com
SOHU
$358M
$15.1M 0.99%
1,075,995
CIH
10
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$11.3M 0.75%
+3,186,499
New +$10.8M
INCY icon
11
Incyte
INCY
$25.7B
$10.1M 0.67%
119,310
+34,500
+41% +$2.77M
SFUN
12
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$10.1M 0.66%
323,617
NBIX icon
13
Neurocrine Biosciences
NBIX
$15.8B
$9.75M 0.64%
118,323
+17,000
+17% +$1.4M
BKD icon
14
Brookdale Senior Living
BKD
$2.81B
$9.54M 0.63%
1,323,000
-1,929,078
-59% -$12.7M
IOVA icon
15
Iovance Biotherapeutics
IOVA
$3.98B
$9.33M 0.62%
413,154
VRCA icon
16
Verrica Pharmaceuticals
VRCA
$91M
$9.23M 0.61%
79,428
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
$8.92M 0.59%
132,605
+11,000
+9% +$770K
FOLD
18
DELISTED
Amicus Therapeutics
FOLD
$8.9M 0.59%
741,969
+160,000
+27% +$2.03M
ARGX icon
19
argenx
ARGX
$64.6B
$8.47M 0.56%
61,483
+7,778
+14% +$987K
BMRN icon
20
BioMarin Pharmaceuticals
BMRN
$12.9B
$8.21M 0.54%
97,650
ASND icon
21
Ascendis Pharma A/S
ASND
$17.7B
$8.1M 0.53%
74,689
+7,263
+11% +$869K
KURA icon
22
Kura Oncology
KURA
$1.18B
$7.34M 0.48%
370,958
+65,000
+21% +$1.08M
BEP icon
23
Brookfield Renewable
BEP
$9.43B
$7.11M 0.47%
225,180
+37,530
+20% +$648K
ABBV icon
24
AbbVie
ABBV
$453B
$6.72M 0.44%
+96,000
New +$7.55M
DB icon
25
Deutsche Bank
DB
$77.7B
$6.43M 0.42%
861,000
+68,000
+9% +$524K

Similar funds

Fosun International's Q2 2019 Portfolio in Review

As of Q2 2019, Fosun International held 339 positions worth $1.51B, down 3.8% from $1.57B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Fosun International deployed $92.2M of net new capital in Q2 2019, opening 32 new positions and adding to 81 existing holdings. Its largest new stake was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 47% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was DigitalBridge, an estimated $14.9M trimmed.

  • Fosun International's largest Q2 2019 buy was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
  • Fosun International added most to Array Biopharma Inc in Q2 2019, an estimated $3.22M increase.
  • Fosun International's biggest Q2 2019 reduction was DigitalBridge, cutting an estimated $14.9M.
  • Fosun International fully exited Baozun in Q2 2019, selling an estimated $20.3M.
  • Fosun International's ten largest holdings make up 50% of its $1.51B portfolio in Q2 2019.
  • Fosun International opened 32 new positions and closed 39 in Q2 2019.
  • Fosun International's portfolio value fell 3.8% quarter-over-quarter to $1.51B.

Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.